Tubulocystic carcinoma of the kidney: Clinicopathologic and molecular characterization

American Journal of Surgical Pathology

Volumn 32, Issue 2, 2008, Pages 177-187

  Yang, Ximing J ^a,b   Zhou, Ming ^c   Hes, Ondrej ^d   Shen, Steven ^e   Li, Rongshan ^f   Lopez, Jose ^g   Shah, Rajal B ^h   Yang, Yu ⁱ   Chuang, Shang Tian ^b   Lin, Fan ^j   Tretiakova, Maria M ^k   Kort, Eric J ^l   Teh, Bin Tean ^l  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d CHARLES UNIVERSITY   (Czech Republic)

^e HOUSTON METHODIST HOSPITAL   (United States)

^f MEDICAL COLLEGE OF WISCONSIN   (United States)

^g UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^h UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

ⁱ PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^j GEISINGER MEDICAL CENTER   (United States)

^k UNIVERSITY OF CHICAGO   (United States)

^l VAN ANDEL RESEARCH INSTITUTE   (United States)

more..

Author keywords

Collecting duct; Cystic; Kidney cancer; Microarray

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTADENOMA; EOSINOPHIL; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY CYST; KIDNEY EPITHELIUM; KIDNEY TUBULE; MALE; METASTASIS; MICROARRAY ANALYSIS; NEPHRECTOMY; PAPILLARY CARCINOMA; PELVIS LYMPH NODE; TUBULOCYSTIC CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 17; CYSTADENOCARCINOMA; DISEASE-FREE SURVIVAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 38649112955     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318150df1d     Document Type: Article

References (29)

1. Allory Y, Ouazana D, Boucher E, et al. Papillary renal cell carcinoma. Prognostic value of morphological subtypes in a clinicopathologic study of 43 cases. Virchows Arch. 2003;442:336-342.
2. Aubert B, Barate R, Boutigny D, et al. Determination of the Branching Fraction for B→X(c)lnu Decays and of |V(cb)| from Hadronic-Mass and Lepton-Energy Moments. Phys Rev Lett. 2004;93:011803.
3. Cheng L, Gu J, Eble JN, et al. Molecular genetic evidence for different clonal origin of components of human renal angiomyolipomas. Am J Surg Pathol. 2001;25:1231-1236.
4. Chuang ST, Chu P, Sugimura J, et al. Overexpression of glutathione s-transferase alpha in clear cell renal cell carcinoma. Am J Clin Pathol. 2005;123:421-429.
5. Dai M, Wang P, Boyd AD, et al. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res. 2005;33:e175.
6. Davidson AJ, Choyke PL, Hartman DS, et al. Renal medullary carcinoma associated with sickle cell trait: radiologic findings. Radiology. 1995;195:83-85.
7. Eble JN, Sauter G, Epstein JI, et al. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon: IARC Press; 2004.
8. Fine SW, Argani P, DeMarzo AM, et al. Expanding the histologic spectrum of mucinous tubular and spindle cell carcinoma of the kidney. Am J Surg Pathol. 2006;30:1554-1560.
9. Furge KA, Lucas KA, Takahashi M, et al. Robust classification of renal cell carcinoma based on gene expression data and predicted cytogenetic profiles. Cancer Res. 2004;64:4117-4121.
10. Gentleman R, Crowley JJ. A graphical approach to the analysis of censored data. Breast Cancer Res Treat. 1992;22:229-240.
11. Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5:R80.
12. Higgins JP, Shinghal R, Gill H, et al. Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. Am J Pathol. 2003;162:925-932.
13. Ihaka R, Gentleman R. R: a language for data analysis and graphics. J Comput Graph Stat. 1996;5:299-314.
14. Irizarry RA, Bolstad BM, Collin F, et al. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003;31:e15.
15. Jiang Z, Iczkowski KA, Woda BA, et al. P504S immunostaining boosts diagnostic resolution of "suspicious" foci in prostatic needle biopsy specimens. Am J Clin Pathol. 2004;121:99-107.
16. Lin F, Brown RE, Shen T, et al. Immunohistochemical detection of P504S in primary and metastatic renal cell carcinomas. Appl Immunohistochem Mol Morphol. 2004;12:153-159.
17. MacLennan GT, Bostwick DG. Tubulocystic carcinoma, mucinous tubular and spindle cell carcinoma, and other recently described rare renal tumors. Clin Lab Med. 2005;25:393-416.
18. MacLennan GT, Farrow GM, Bostwick DG. Low-grade collecting duct carcinoma of the kidney: report of 13 cases of low-grade mucinous tubulocystic renal carcinoma of possible collecting duct origin. Urology. 1997;50:679-684.
19. Paner GP, Srigley JR, Radhakrishnan A, et al. Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney: significant immunophenotypic overlap warrants diagnostic caution. Am J Surg Pathol. 2006;30:13-19.
20. Rohan S, Tu JJ, Kao J, et al. Gene expression profiling separates chromophobe renal cell carcinoma from oncocytoma and identifies vesicular transport and cell junction proteins as differentially expressed genes. Clin Cancer Res. 2006;12:6937-6945.
21. Shen SS, Ro JY, Tamboli P, et al. Mucinous tubular and spindle cell carcinoma of kidney is probably a variant of papillary renal cell carcinoma with spindle cell features. Ann Diagn Pathol. 2007;11:13-21.
22. Takahashi M, Yang XJ, Lavery TT, et al. Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features. Cancer Res. 2002;62:6598-6605.
23. Takahashi M, Sugimura J, Yang X, et al. Gene expression profiling of renal cell carcinoma and its implications in diagnosis, prognosis, and therapeutics. Adv Cancer Res. 2003;89:157-181.
24. Tretiakova MS, Sahoo S, Takahashi M, et al. Expression of alphamethylacyl-CoA racemase in papillary renal cell carcinoma. Am J Surg Pathol. 2004;28:69-76.
25. Wang KL, Weinrach DM, Luan C, et al. Renal papillary adenoma - a putative precursor of papillary renal cell carcinoma. Hum Pathol. 2007;38:239-246.
26. Yang XJ, Sugimura J, Tretiakova MS, et al. Gene expression profiling of renal medullary carcinoma: potential clinical relevance. Cancer. 2004;100:976-985.
27. Yang XJ, Tan MH, Kim HL, et al. A molecular classification of papillary renal cell carcinoma. Cancer Res. 2005;65:5628-5637.
28. Yang XJ, Sugimura J, Schafernak KT, et al. Classification of renal neoplasms based on molecular signatures. J Urol. 2006;175:2302-2306.
29. Young AN, Amin MB, Moreno CS, et al. Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. Am J Pathol. 2001;158:1639-1651.